CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-10 | Orlando Daniel Chief Operating Officer | Sale | −500 | $13.10 | $7K | 12,518 |
| 2018-05-10 | Orlando Daniel Chief Operating Officer | Option exercise | +22,687 | $3.57 | $81K | 35,205 |
| 2018-05-10 | Orlando Daniel Chief Operating Officer | Sale | −2,687 | $13.00 | $35K | 32,518 |
| 2018-05-10 | Orlando Daniel Chief Operating Officer | Sale | −1,000 | $13.10 | $13K | 31,518 |
| 2018-05-10 | Orlando Daniel Chief Operating Officer | Sale | −15,000 | $13.05 | $196K | 16,518 |
| 2018-05-10 | Orlando Daniel Chief Operating Officer | Sale | −1,000 | $13.00 | $13K | 15,518 |
| 2018-05-10 | Orlando Daniel Chief Operating Officer | Sale | −2,000 | $13.05 | $26K | 13,518 |
| 2018-05-10 | Orlando Daniel Chief Operating Officer | Sale | −1,000 | $13.05 | $13K | 12,518 |
| 2018-05-10 | Orlando Daniel Chief Operating Officer | Option exercise · Stock Option (right to buy) | −22,687 | 0 | ||
| 2018-05-02 | Hagen Heidi Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2018-05-02 | MCLAUGHLIN KEVIN F Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2018-05-02 | GILMAN STEVEN C Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2018-05-02 | Rubino Alan L Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2018-05-02 | Wotton Paul K Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2018-05-02 | ZERBE ROBERT L MD Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2018-03-16 | Rubino Alan L Director | Purchase | +165 | $11.58 | $2K | 165 |
| 2018-03-16 | Rubino Alan L Director | Purchase | +685 | $11.57 | $8K | 850 |
| 2018-03-16 | Rubino Alan L Director | Purchase | +40 | $11.50 | $460 | 40 |
| 2018-02-20 | Colangelo Dominick President and CEO | Option exercise | +27,500 | $3.02 | $83K | 64,804 |
| 2018-02-20 | Colangelo Dominick President and CEO | Option exercise | +6,603 | $3.57 | $24K | 71,407 |
Page 65 of 75 · 1,497 trades